Notably, CR rate in LEP hypermethylated patients was significantly lower than that in LEP non-hypermethylated patients among whole-cohort AML and non-M3 AML (P = 0.011 and 0.049, respectively, Table 1). This evidence concerns the gene LEP and acute myeloid leukemia.